Baiyunshan: Subsidiary Obtains Drug Supplement Application Approval.

Baiyunshan Announcement: Chen Li Ji Pharmaceutical Factory, a subsidiary, has received the "Drug Supplementary Application Approval Notice" issued by the National Drug Administration. The generic name of the drug is Qianjin Baoyun Pill, dosage form is pill, notice number is 2025B01053, acceptance number is CYZB2401460, and drug registration standard number is YBZ00162025. The original drug approval number was Z44022637. The application is to change the drug specifications, the approval conclusion is to approve the supplementary application for changing the drug specifications of this product, and to increase the specifications of Xiaomi Pill, with a specification of 10g for every 40 pills and a shelf life of 24 months.